bpc 157 human case report clinical trial BPC-157: Miracle Healing Peptide or Hidden Danger? Columbia Undergraduate Science Journal

Switch from cyanocobalamin to methylcobalamin (or vice versa), drop the dose, or change the delivery route

It is important to mention that elevated CXCL10 and HGF levels, along with decreased IL-10 protein levels, have been associated with worsening cognitive function from recruitment to the six-month follow-up in the previous study by Souza-Silva et al

Further, NASO B12 was well-tolerated throughout the treatment period.[] Patients on metformin therapy receiving NASO B12 should also be instructed that they will require weekly intranasal administration of NASO B12 spray in each nostril after correction of vitamin B12 deficiency for the remainder of their lives

Research suggests methylcobalamin stays in the body longer while cyanocobalamin may be more easily absorbed, but other studies have found little difference in the two in absorption and retention

For those managing a confirmed deficiency rather than simply maintaining levels, the treatment approach shifts significantly